We produced a hybridoma secreting an immunoglobulin Gl monoclonal antibody against the circumsporozoite protein of the human malaria parasite Plasmodium malariae (Uganda 1/CDC). The Irradiated malaria sporozoites, when inoculated into recipient animals either intravenously or by the bites of infected mosquitoes, induce a protective immune response which is both stage and species specific. Thus rodents, rhesus monkeys, and human volunteers have been successfully immunized against malaria infection by repeated inoculation with radiation-attenuated sporozoites (2).
Irradiated malaria sporozoites, when inoculated into recipient animals either intravenously or by the bites of infected mosquitoes, induce a protective immune response which is both stage and species specific. Thus rodents, rhesus monkeys, and human volunteers have been successfully immunized against malaria infection by repeated inoculation with radiation-attenuated sporozoites (2).
The protection is at least in part antibody mediated. Previous studies, using monoclonal antibodies (moAB) produced against salivary gland sporozoites of rodent (12, 18) and simian malaria (3) and the human parasites Plasmodilum vivax and Plasmodiium falciparium (10) , have shown that incubation of sporozoites with homologous moAB can abolish parasite infectivity and that passive transfer of moAB protects mice against challenge with sporozoites of Plasmodium berghei. These same studies have indicated that the protective response of the host is directed against an immunodominant surface antigen which uniformly and densely covers the entire membrane of the sporozoite. These antigens, which we have designated circumsporozoite (CS) proteins, are processed from high-molecular-weight intracellular precursor polypeptides. CS proteins, like the protective response they elicit, are strictly stage and species specific.
In the present investigation we used moAB produced against sporozoites of the human malaria parasite Plasmodium malariae to identify and characterize the CS protein of this parasite and to define the relationship of P. malariae with the simian parasite Plasmodium brasilianum.
MATERIALS AND METHODS Sporozoites. Using previously described methodology (16), we recovered sporozoites of P. malariae ( (17) , viable sporozoites were incubated at 37°C for 30 min with an equal volume of sera of either hybridoma-bearing or sporozoite-immunized mice. Morphological alteration of the parasites was determined by phase-contrast microscopy. Sporozoites which had been mildly heat-fixed and then frozen at -70°C were used as the antigen for immunofluorescence (9) .
Immunization of mice and production of hybridoma. Adult BALB/c mice were immunized by multiple intravenous inoculations of a total of 1.2 x 105 viable midgut and salivary gland sporozoites of P. malariae. At day 4 after the last immunizing dose, when antisporozoite antibodies were detected in the serum of an immunized animal by both the CSP reaction and indirect immunofluorescence, immune spleen cells were recovered and fused with P3U1 plasmacytoma cells (7, 12) . Production of the hybridoma and purification of moAB from mouse ascites by salt precipitation and molecular sieve chromatography were as described previously (12) .
Western immunoblot. To identify the CS protein of P. malariae we used Western blot analysis (15) essentially as previously described for detection of CS proteins of other malaria parasites (A. H. Cochrane, C. F. Ockenhouse, and R. S. Nussenzweig, J. Immunol. Methods, in press). Viable sporozoites were placed directly in sample reducing buffer containing 2% sodium dodecyl sulfate (SDS), 10% glycerol, 20% f-mercaptoethanol, and 6 M urea for 1 h. The extract was subjected to SDS-polyacrylamide gel electrophoresis, using a 10% running gel (8) , and then electroblotted to a nitrocellulose membrane (Bio-Rad Laboratories, Richmond, Calif.). The membrane was incubated overnight with phosphate-buffered saline (PBS) containing 5% bovine serum albumin (BSA) and then incubated for 2 h with either purified P. malariae moAB at a concentration of 20 ,ug/ml in PBS-BSA or mouse immune serum (IS) raised against P. malariae sporozoites at a final dilution of 1:50 in the same buffer. Negative controls were incubated under the same conditions with a noncross-reacting moAB (3D11) produced against the CS protein of the rodent parasite P. ber,ghei or with IS raised against either P. berghei sporozoites or uninfected salivary glands ofAnophelesfreeborni. All preparations were washed three times with PBS-BSA and then incubated for 2 h with 1.0 x 106 cpm of affinity-purified goat anti-mouse '25I-labeled immunoglobulin. After washings in PBS-BSA and PBS-BSA containing 0.05% Tween 20, the preparations were autoradiographed at -70°C with an XOmat AR film and an image-intensifying screen.
Two-dimensional electrophoretic analysis of CS protein by Western blot. Two-dimensional electrophoresis was performed according to a modification (6) of the O'Farrell technique (11) . Viable sporozoites were placed directly in sample buffer consisting of 8% Ampholines (pH 5 to 7) (LKB Instruments, Inc., Bromma, Sweden), 8% 3-mercaptoethanol, 4% Nonidet P-40, and 6 M urea. An extract of ca. 2.0 x 104 sporozoites was loaded at the cathodic end of the isoelectric focusing gel and separated in the first dimension by isoelectric focusing and in the second dimension by SDSpolyacrylamide gel electrophoresis. Immunoblot analysis with P. malariae moAB was as described above.
Two-site IRMA. We tested the P. malariae moAB for reactivity with sporozoite antigen of P. malariae and seven other malaria species by using a two-site immunoradiometric assay (IRMA) as described earlier (21) . Wells of microtiter plates were incubated overnight at 27°C with 50 ,ul of PBS containing purified moAB at a concentration of 10 pLg/ml. They were washed three times with PBS-BSA and incubated with the same buffer for 1 h at room temperature. Thirtymicroliter volumes of PBS-BSA-0.1% Nonidet P-40 containing an extract of 1,000 to 2,000 sporozoites, prepared as described previously (21) , were added in duplicate to the wells. After a 2-h incubation at room temperature, the wells were thoroughly washed with PBS-BSA, and 30,ul of moAB labeled with 1251 (ca. 105cpm) was added to each well. After an additional 1-h incubation, the wells were washed three times with PBS-BSA containing 0.05% Tween 20, dried, and counted in a gamma counter. The radioactivity (counts per minute) resulting from nonspecific binding of each sporozoite antigen by the P. malariae moAB was measured by using an unrelated cold moAB to bind sporozoite antigen to the microtiter wells. These values were subtracted from the counts per minute obtained with the P. malariae moAB and the various sporozoite extracts for determination of specific interactions.
RESULTS
Characterization of moAB. One hybrid cell line secreting antisporozoite antibody was isolated and cloned. The moAB 6B10 is an immunoglobulin Gl. When incubated with viable sporozoites, the moAB mediates the CSP reaction and reacts at high titers (1::50,000) in the indirect immunofluorescent antibody test with mildly heat-fixed sporozoites as the antigen.
Identification of CS protein. We used Western blot analysis, as described above, to determine the molecular weight of the P. malariae CS protein (Fig. 1) . Sporozoite extract in sample reducing buffer was electrophoresed on an SDSpolyacrylamide gel and transferred to nitrocellulose membrane. The CS protein was probed with either moAB or IS and developed with affinity-purified 125I-labeled goat anti- mouse immunoglobulin. Both IS (Fig. 1, lane 1) raised in mice against P. malariae sporozoites and moAb 6B10 (lane 2) identified a specific protein with the approximate molecular weight of 48,000 (Pm 48). In addition, MoAB 6B10 identified a P. malariae sporozoite-specific protein with a molecular weight of 60,000 (Pm 60). These proteins were not recognized by the P. berghei moAB 3D11 (Fig. 1, lane 3) or IS raised against either sporozoites of P. berghei (lane 4) or uninfected salivary glands of Anopheles freeborni (lane 5).
Two-dimensional electrophoretic analysis of CS protein. As determined by isoelectric focusing in acrylamide gel and Western blot analysis, the isoelectric point of the P. malariae CS protein Pm 48 was 4.7 to 5.0; the isoelectric point of the higher-molecular-weight protein Pm 60 was 5.3 (Fig. 2) .
CS protein contains two or more identical epitopes. The repetitive nature of the epitope recognized by moAB 6B10 was shown by using a two-site as described above. The same moAB was used both in the solid phase to bind sporozoite antigen and in the fluid phase as a radiolabeled developing reagent. This assay readily detected the P. malariae sporozoite antigen, indicating the presence of at least two identical antigenic determinants (Fig. 3) .
Specificity of reactivity of moAB 6B10. We tested the P. (Fig. 3) . DISCUSSION In the present study, we produced a hybridoma secreting moAB (6B10) against sporozoites of P. malariae and used this moAB to identify and characterize the CS protein of this parasite. As shown by both the CSP reaction and indirect immunofluorescence, the moAB reacts with an antigen located on the surface membrane of the sporozoite. By Western blot analysis, we found the P. malariae moAB to recognize two sporozoite-specific proteins with apparent molecular weights of 60,000 (Pm 60) and 48,000 (Pm 48). IS, raised in mice immunized with P. malariae sporozoites, identified Pm 48. The antigenic determinant recognized by moAB 6B10 appears to be repetitive. The isoelectric points of both Pm 60 and Pm 48 are acidic and the isoelectric point of Pm 48 is lower than that of Pm 60.
Our previous studies have shown that the surface membrane of sporozoites of rodent (12, 18) , simian (3), and the human malaria parasites P. falciparum and P. vivax (10) bears a single immunodominant antigen designated CS protein which arises from an intracellular precursor molecule (3, 19) . By comparison of the physicochemical properties of P. malariae sporozoite antigens with those previously determined for sporozoites of other plasmodial species (14, 20) , we consider it likely that Pm 48 is the surface CS protein and Pm 60 is the intracellular precursor. However, due to the limited availability of sporozoites, we were not able to directly determine the cellular localization of these proteins nor their precursor-product relationship.
One very interesting observation was the cross-reactivity of the P. malariae moAB with sporozoites of the simian malaria parasite P. brasilianum, indicating the complete or near identity of epitopes on the CS proteins of the two species. This is the first observation on the reactivity of an moAB produced against the CS protein of a human malaria with sporozoites of a simian malaria. A close relationship between P. malariae and P. brasilianum has long been indicated by previous studies of the morphology and differ- entiation of exoerythrocytic and erythrocytic parasites as well as sporogonic stages within the mosquito host (1). These observations, and the fact that P. brasilianum can be readily established experimentally in humans by sporozoite inoculation (4), led Coatney et al., in their 1971 definitive study of primate malarias, to propose that P. brasilianum is, in fact, a strain of P. malariae which became adapted to New World monkeys sometime after the early 1600s (1).
The availability of the P. malariae moAB will facilitate the future identification of the CS protein-encoding gene of the two species, as in the case of P. knowlesi (5) . The comparative analysis of total parasite DNA, using the Southern blotting technique, will further clarify the evolutionary relationship between the two species. In addition, the moAB can be used in the IRMA described by Zavala et al. (21) 
